SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-24-008385
Filing Date
2024-06-14
Accepted
2024-06-14 16:11:14
Documents
14
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp212847_8k.htm   iXBRL 8-K 66955
2 EXHIBIT 3.1 dp212847_ex0301.htm EX-3.1 341056
  Complete submission text file 0000950103-24-008385.txt   638139

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adct-20240613.xsd EX-101.SCH 3036
4 XBRL LABEL FILE adct-20240613_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adct-20240613_pre.xml EX-101.PRE 22373
17 EXTRACTED XBRL INSTANCE DOCUMENT dp212847_8k_htm.xml XML 3765
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39071 | Film No.: 241044866
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)